Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.
about
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisFrom pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentPharmacogenetics of antidepressant response.Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.Potential mechanisms of action of lithium in bipolar disorder. Current understanding.[Physiopathology of bipolar disorders: what have changed in the last 10 years?].Anticonvulsants: aspects of their mechanisms of action.G protein-coupled receptors in major psychiatric disorders.[The etiopathogenesis of unipolar depression. Neurobiological and psychosocial factors].Psychopharmacogenetics--a challenge for pharmacotherapy in psychiatry.Mood stabilizer psychopharmacologyMolecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.Evaluation of neurotoxic potential by use of in vitro systems.Bcl-2 immunoreactive neurons are differentially distributed in subregions of the amygdala and hippocampus of the adult macaque.The cyclic AMP phenotype of fragile X and autismA drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.Valproate and neuroprotective effects for bipolar disorder.Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.Differential display RT-PCR reveals genes associated with lithium-induced neuritogenesis in SK-N-MC cells.Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation.Effects of Lithium Monotherapy for Bipolar Disorder on Gene Expression in Peripheral LymphocytesChronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid.Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919).Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid.A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate.G-protein beta3 subunit C825T polymorphism tends to be associated with seasonal variation in young male college students.Association of G-Protein β3 Subunit C825T Polymorphism with Seasonal Variations in Mood and Behavior.NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.
P2860
Q24651407-1FBF2246-98E0-4F27-90F6-622A5FD10A60Q27015830-0D8D03B2-7F93-4AC7-A41D-4567C5E79843Q34155796-3D026B0B-1CEC-4523-8E1F-979FA6659EA1Q34180376-5F36AEA9-B2E8-4A32-9620-71F650AE0042Q34325612-B8B0F0BB-4E3F-4B30-A015-E5A2EE25A170Q34376230-745C4D8F-DEBD-4236-BF45-DA5D4FC11908Q34558509-400A99B9-72A9-454F-8663-A39DE9ACDE0FQ34578414-FFF121F3-099D-4811-9950-0EF4FFE32804Q34763926-A79E9790-0249-46EE-A353-2333BF22A057Q35066468-87E7F4BF-0E5E-4C1F-8068-E2FB7C89DC49Q36031634-A2A71C7D-A2AE-4C91-BFE6-9BE085A70CD1Q36206254-B1A31991-3A9B-4311-A2C0-18D2F9480CAAQ36544892-0B23BB10-A433-4AB2-B160-40BAABEBFC92Q36731473-4FD82924-6113-436C-BE9B-28ED1962FEB9Q37097136-9241A767-1C6B-474C-9D1D-DF5FE6B5A46CQ37395737-9A739FC6-A8BA-4E24-9453-8D08940E035EQ37726041-31C30FAA-EC27-477D-89B7-CBD640BD8A9AQ39441772-4D8637D9-D8C9-4588-9C06-D1EE0E7D097CQ39547248-DF9C16E1-15E7-41FF-85A7-F9A64E4529E7Q39851823-E5BD9E58-5A43-4255-BFA7-4100C64EB2F2Q41653853-D223BEB7-D2AA-46E2-9E8D-700379004FA9Q45161646-9C72C956-29CE-4508-BEA6-29F2A952F804Q45245228-0AC0363D-F54E-45FE-83DC-554B57DA87F3Q46423984-0F35C8B4-B7EC-4A7A-ACAE-13141C2497FEQ48064476-7185A284-0088-4BE5-932F-3E4BFA9AD399Q50959417-D03FA058-912E-4216-9088-5452C189A826Q55280317-358F3D66-2BFF-4AAE-9584-54440760D6FAQ55330019-EC509BED-986D-4150-A452-4BF9CCBC3997
P2860
Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Regulation of signal transduct ...... abilizers and antidepressants.
@ast
Regulation of signal transduct ...... abilizers and antidepressants.
@en
type
label
Regulation of signal transduct ...... abilizers and antidepressants.
@ast
Regulation of signal transduct ...... abilizers and antidepressants.
@en
prefLabel
Regulation of signal transduct ...... abilizers and antidepressants.
@ast
Regulation of signal transduct ...... abilizers and antidepressants.
@en
P2093
P1476
Regulation of signal transduct ...... abilizers and antidepressants.
@en
P2093
P304
P356
10.1097/00006842-199909000-00004
P407
P577
1999-09-01T00:00:00Z